Despite several lines of evidence indicating an association between increased MPO concentrations and HF pathogenesis and severity, the clinical benefit of MPO inhibition in HF patients remains unknown (Ng et al., 2006; Tang et al., 2006, 2007; Reichlin et al., 2010; Ndrepepa, 2019). The gene discussed is MPO; the disease is hydrops fetalis.